As we now have two feet into 2025, we thought we would share a snapshot of some of the predicted trends that will be driving the MedTech landscape this year.
Although there are natural continuations of trends and innovation from previous years, the sector is experiencing rapid advancements driven by technological innovation, evolving healthcare needs, and a focus on personalised healthcare. The intersection of technology and healthcare is reshaping the way medical products are developed and used, improving patient outcomes and operational efficiencies. Here are some of the key trends in MedTech product development that are set to define 2025:
AI and Machine Learning Integration
Artificial Intelligence (AI) and Machine Learning (ML) continue to be integral in MedTech product development. These technologies are enabling predictive analytics, personalised treatment plans, and enhanced diagnostic tools. AI-powered devices are now capable of interpreting complex medical data, offering real-time insights that aid in faster and more accurate diagnoses.
eg technology continuously monitor the development of AI and the legislative frameworks that are being put in place for the incorporation of AI into the medical software and device development processes. With our background in developing medical devices, we understand the rigor and necessary procedures required to bring a successful medical product to market. Going forward, the use of AI components ‘in device’ (or cloud software for healthcare systems), will undoubtedly need to comply with regulations and incorporate thorough risk analysis and real-world processing examples. This will ensure that the AI element is consistent and reproducible across a variety of expected scenarios.
Remote Monitoring
The global shift towards remote monitoring or telemedicine, accelerated by the COVID-19 pandemic, continues to influence MedTech product development. Wearable devices and remote monitoring tools are becoming more sophisticated, offering continuous patient data tracking and real-time health monitoring. This trend is particularly beneficial for managing chronic diseases and reducing hospital visits.
The growing requirement for medical devices to be ‘connected’ or cloud-based has various development and rollout implications and there are key considerations which must not be overlooked when developing IoMT systems. These include complying with relevant medical standards, choosing an appropriate connection method, personal data security, cybersecurity and the user experience (UX). This can make the task difficult and time consuming, if not properly managed. It is therefore important when developing a device to ask the right questions around connectivity: Should the device always be connected? Will it always have connectivity? What are the benefits? How is data aggregated, stored, shared and managed? Should incorporating IoT be a primary focus? Will integrating connectivity actually act as a barrier to adoption?
These are questions that we, at eg, answer early in our development and through prototyping and user testing. The highest areas of risk can be assessed before moving towards a pre-production design. By incorporating an explicit understanding of the users, tasks and environment, the end product is far more likely to meet expectations, requirements and regulations.
Cybersecurity in Medical Devices
With the increasing connectivity of medical devices, cybersecurity has become a critical concern. In 2025, there is a heightened focus on developing secure devices that protect patient data and prevent unauthorized access. Regulatory bodies are emphasising stringent cybersecurity protocols in the product development lifecycle.
With potentially sensitive personal data being collected by connected medical devices, more stringent regulation and clearer guidance in medical device development has been a growing requirement. Since the rollout in 2017, new devices must meet MDR requirements before they can be launched onto European markets. The FDA have also published numerous pieces of guidance relating to cybersecurity of medical devices; including ‘Postmarket management of cybersecurity in medical device’ in 2016, and updates to the ‘Content of premarket submissions for device software functions’. In the 2nd week of January they posted a draft guidance on artificial intelligence (AI)- enabled medical devices, which emphasises the need for robust cybersecurity measures in medical device development, with a focus on authenticity (which includes integrity), authorisation, availability, confidentiality, and secure and timely updatability and patchability.
Regenerative Medicine and Tissue Engineering
Advances in regenerative medicine and tissue engineering are opening new possibilities in MedTech. Researchers are developing innovative therapies that repair or replace damaged tissues and organs. Stem cell research, bioengineered tissues, and gene editing technologies are at the forefront of this trend.
We work closely with numerous Pharma, Lab & BioTech clients to develop platforms that further their research objectives. Our mechanical and build teams are able to provide a phased design for manufacture, during which they manage requirement specifications, calculations, pneumatics, failure modes and effects analysis (FMEA), usability, prototyping and controlled build. This expertise was leveraged by CN Bio, with whom we worked to develop their PhysioMimix Organ-on-Chip device, specifically designed for the research of drug metabolism, toxicology and liver disease. As their chosen development partner, we used our expertise in mechanical and pneumatic design to drive their innovative microfluidics platform and turn the product into reality.
Wearable HealthTech
Wearable HealthTech is evolving beyond fitness trackers to include advanced health monitoring devices. These wearables are capable of measuring vital signs, detecting arrhythmias, and even predicting potential health issues. The integration of wearables with mobile apps is providing users with actionable health insights.
In the development pathway, it is critical to consider the classification of wearable devices – is it actually a medical device? – as well as the usability. User expectations have shifted with the prevalence of wearable devices, especially as many now have the appearance of being ‘medical’ – such as health trackers. Users, therefore, have an expectation as to how the UI should look, feel and operate, as well as how the device itself looks, how it charges and how it fits into their daily lives. This expectation is obviously dependent on the situation in which the device is used, and by whom, but as consumer devices evolve, medical UIs are expected to assimilate. User studies allow you to assess expectations and challenge assumptions within your development.
Sustainability in MedTech
Sustainability is becoming a priority in MedTech product development. Companies are focusing on eco-friendly materials, reducing waste, and developing products with a lower environmental impact. This trend is not only addressing environmental concerns but also meeting the expectations of eco-conscious consumers and regulatory requirements.
eg technology has seen growing interest in sustainable product development and life cycle assessment across sectors. Integrating sustainable materials into medical device design is possibly the most challenging as the very nature of many medical devices does not always align with eco-friendly materials. However, we work closely with our clients and know how to define the right specifications, incorporating sustainability credentials for their product to fulfil its technical, customer and compliance requirements for seamless integration into commercial pathways. We help our clients align their sustainable product development goals with market needs and regulations at each stage of the end-to-end development process, whilst establishing full lifecycle management.
Robotics in Surgery
Robotic-assisted surgery is becoming more refined, offering precision and enabling minimally invasive procedures. In 2025, we can expect to see more advanced surgical robots that enhance surgeon capabilities and reduce recovery times for patients. This technology is particularly impactful in complex procedures like neurosurgery and orthopaedics. Alongside robotics, is the potential of ‘telesurgery’. In September, a doctor in France carried out a robotic nephrectomy on a patient in Beijing. Although this surgery was a success, there are questions that must be answered around latency, precision, regulatory and ethical concerns, and 5G development.
We recently shared a blog about ‘putting the human in AI development’, which seems particularly poignant for robotics in surgery. Not only will the software, regulatory compliance and risk management be critical in the product development, but usability and human factors will have to play a leading role, to ensure that these technologies are effective, safe, and user-friendly.
Personalised Medicine
Personalised medicine is at the core of many new MedTech products. By leveraging genetic information and patient data, products are being developed to cater to individual health needs. This trend is driving the development of targeted therapies and customised treatment plans that improve patient outcomes.
When attempting to turn a novel, lab-based test into a market-disrupting, clinical, certified, diagnostic product, our recommendation is to start with the user. At eg, we place huge importance on mapping out the user workflow in relation to the clinical pathway, with special attention to where the test, device and other development aspects intersect. By tailoring different user studies to each stage of your project and incorporating other defined criteria – such as risk levels, use environment and workflow – we regularly transform conceptual and lab-scale set-ups, processes and technologies into robust, marketable products.
Regulatory Innovations
The regulatory landscape is evolving to keep pace with rapid technological advancements. In 2025, we see more adaptive regulatory frameworks that encourage innovation while ensuring patient safety. Regulatory bodies are also adopting digital tools for faster approval processes, making it easier for innovative products to reach the market.
As an ISO 13485 accredited medical device development consultancy, we have a deep understanding of the unique challenges and regulatory requirements of the MedTech industry, including FDA compliance, CE marking and UKCA marking. Our team have a wealth of practical experience in getting medical devices through regulatory testing, such as the IEC 60601 series for medical electrical equipment, IEC 62304 for medical device software and IEC 62366 for medical device usability. We keep abreast of any regulatory developments in the MedTech sector, ensuring every medical device we develop complies with the latest standards. Read our blog on navigating medical device standards for a snapshot of the various regulations.
Conclusion
The MedTech sector is poised for transformative growth in 2025, with technological advancements driving innovation and improving patient care. Companies that stay ahead of these trends, focusing on integrating AI, ensuring cybersecurity, embracing sustainability, and fostering personalised medicine, will be at the forefront of this dynamic industry. As the landscape evolves, collaboration between technology developers, healthcare providers, and regulators will be crucial in bringing next-generation medical products to life.
eg technology are experts in healthcare innovation and developing medical devices. With clients across MedTech, FemTech, Lab & BioTech, Pharma, Life Sciences and Consumer Healthcare, we are skilled and experienced at solving complex engineering problems and creating safe, compliant and reliable medical devices to maximise commercial viability. Whether you are a start-up looking to bring a groundbreaking medical device to market, or an established company seeking to evolve your product offerings – or gain that crucial FDA compliance, CE marking, or UKCA marking – we can help you navigate the complex regulatory landscape with a meticulous approach to compliance. Please get in touch with our team today.
If would like to chat with one of our team about your product design and development requirements, please do not hesitate to get in touch:
Via email on design@egtechnology.co.uk, by giving us a call on +44 01223 813184, or by clicking here.